Cost effectiveness of pharmacogenetic screening prior to initiation of carbamazepine treatment for epilepsy
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Cost effectiveness of pharmacogenetic screening prior to initiation of carbamazepine treatment for epilepsy. / Plumpton, C. O.; Yip, V; Alfirevic, A. et al.
Yn: Value in Health, Cyfrol 16, Rhif 7, 11.2013, t. A624-A624.
Yn: Value in Health, Cyfrol 16, Rhif 7, 11.2013, t. A624-A624.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Plumpton, CO, Yip, V, Alfirevic, A, Marson, A, Pirmohamed, M & Hughes, D 2013, 'Cost effectiveness of pharmacogenetic screening prior to initiation of carbamazepine treatment for epilepsy', Value in Health, cyfrol. 16, rhif 7, tt. A624-A624. https://doi.org/10.1016/j.jval.2013.08.1831
APA
Plumpton, C. O., Yip, V., Alfirevic, A., Marson, A., Pirmohamed, M., & Hughes, D. (2013). Cost effectiveness of pharmacogenetic screening prior to initiation of carbamazepine treatment for epilepsy. Value in Health, 16(7), A624-A624. https://doi.org/10.1016/j.jval.2013.08.1831
CBE
Plumpton CO, Yip V, Alfirevic A, Marson A, Pirmohamed M, Hughes D. 2013. Cost effectiveness of pharmacogenetic screening prior to initiation of carbamazepine treatment for epilepsy. Value in Health. 16(7):A624-A624. https://doi.org/10.1016/j.jval.2013.08.1831
MLA
Plumpton, C. O. et al. "Cost effectiveness of pharmacogenetic screening prior to initiation of carbamazepine treatment for epilepsy". Value in Health. 2013, 16(7). A624-A624. https://doi.org/10.1016/j.jval.2013.08.1831
VancouverVancouver
Plumpton CO, Yip V, Alfirevic A, Marson A, Pirmohamed M, Hughes D. Cost effectiveness of pharmacogenetic screening prior to initiation of carbamazepine treatment for epilepsy. Value in Health. 2013 Tach;16(7):A624-A624. doi: 10.1016/j.jval.2013.08.1831
Author
RIS
TY - JOUR
T1 - Cost effectiveness of pharmacogenetic screening prior to initiation of carbamazepine treatment for epilepsy
AU - Plumpton, C. O.
AU - Yip, V
AU - Alfirevic, A.
AU - Marson, A.
AU - Pirmohamed, M.
AU - Hughes, Dyfrig
PY - 2013/11
Y1 - 2013/11
U2 - 10.1016/j.jval.2013.08.1831
DO - 10.1016/j.jval.2013.08.1831
M3 - Article
VL - 16
SP - A624-A624
JO - Value in Health
JF - Value in Health
SN - 1098-3015
IS - 7
ER -